Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2002-09-25
2008-10-28
Coleman, Brenda L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S269000, C514S335000, C514S336000, C514S337000, C514S338000, C514S339000, C514S341000, C514S342000, C514S343000, C514S347000, C544S333000, C544S405000, C546S261000, C546S269700, C546S275100, C546S275400, C546S276100, C546S277400, C546S278400, C546S280400
Reexamination Certificate
active
07442702
ABSTRACT:
This invention relates to prostaglandin agonists, methods of using such prostaglandin agonists, pharmaceutical compositions containing such prostaglandin agonists and kits containing such prostaglandin agonists. The prostaglandin agonists are useful for the treatment of bone disorders including osteoporosis.
REFERENCES:
patent: 3442890 (1969-05-01), Larsen et al.
patent: 3528961 (1970-09-01), Miles et al.
patent: 3780095 (1973-12-01), Klemm et al.
patent: 3987091 (1976-10-01), Cragoe et al.
patent: 3991106 (1976-11-01), Cragoe et al.
patent: 4033996 (1977-07-01), Cragoe et al.
patent: 4055596 (1977-10-01), Cragoe et al.
patent: 4097601 (1978-06-01), Schaaf
patent: 4112236 (1978-09-01), Bicking et al.
patent: 4175203 (1979-11-01), Cragoe et al.
patent: 4243678 (1981-01-01), Krastinat
patent: 4386031 (1983-05-01), Hilboll et al.
patent: 4443477 (1984-04-01), Witte et al.
patent: 4761430 (1988-08-01), Choay et al.
patent: 4911888 (1990-03-01), Fikentscher et al.
patent: 6251917 (2001-06-01), Lubisch et al.
patent: 6852863 (2005-02-01), Cameron et al.
patent: 2003/0166631 (2003-09-01), Dumont et al.
patent: 0897566 (1983-12-01), None
patent: 0608847 (1994-08-01), None
patent: 1478281 (1977-06-01), None
patent: 1479156 (1977-07-01), None
patent: 2233644 (1991-01-01), None
patent: 5019756 (1975-03-01), None
patent: WO9731640 (1997-09-01), None
patent: WO9828264 (1998-07-01), None
patent: WO9919300 (1999-04-01), None
Sartori, E., et al.,Eur. J. Med. Chem., “Synthesis and Activities of New Arylsulfonamido Thromboxane A2 Receptor Antagonists”, vol. 28, pp. 625-632 (1993).
The Merck Index, 12 Edition, Merck & Co. Inc., pp. 43, 583, 1394, 1548 (1996).
Bicking, J.B., et al.,Journal of Med. Chem, “11,12-Secoprostaglandins. 5. 8-Acetyl-or 8-(1-Hydroxyethyl)-12-hydroxy-13-aryloxytridecanoic Acids and Sulfonamide Isosteres as Inhibitors of Platelet Aggregation”, vol. 21, No. 10, pp. 1011-1018 (1978).
Billman, J., et al.,J. Org. Chem., “Reduction of Schiff Bases. III. Reduction with Dimethylamine Borane”, vol. 26, pp. 1437-1440 (1961).
Jones, J.H., et al.,Journal of Med. Chem., “11, 12-Secoprostaglandins. 4. 7-(N-Alkylmethanesulfonamido) Heptanoic Acids”, vol. 20, No. 10, pp. 1299-1304 (1977).
Bolander, ME, et al, 38th Annual Meeting, Orthopedic Research Society, p. 138 (1992).
Partial Translation of Citation 6, Japanese Patent Laid-Open Publication # Sho 50-19756 (1975).
Cameron Kimberly O.
Lefker Bruce A.
Rosati Robert L.
Benson Gregg C.
Coleman Brenda L
Pfizer Inc.
Wichtowski John A.
LandOfFree
Prostaglandin agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prostaglandin agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostaglandin agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4014564